| 75706-12-6 Basic information More.. |
Product Name: | Leflunomide | Synonyms: | LEFLUNOMIDE;HWA 486;ALPHA,ALPHA,ALPHA-TRIFLUORO-5-METHYL-4-ISOXAZOLECARBOXY-P-TOLUIDIDE;5-METHYLISOXAZOLE-4-(4-TRIFLUOROMETHYLCARBOXANILIDE);5-METHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]-4-ISOXAZOLECARBOXAMIDE;N-(4-TRIFLUOROMETHYLPHENYL)-5-METHYLISOXAZOL-4-CARBOXAMIDE;5-methylisoxazole-4-carboxylicacid(4-trifluoromethyl)anilide;5-methyl-n-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamid | CAS: | 75706-12-6 | MF: | C12H9F3N2O2 | MW: | 270.21 | EINECS: | 616-254-6 | Mol File: | 75706-12-6.mol | |
Use
Leflunomide (Arava), an isoxazole prodrug, is an orally activeDMARD marketed in 1998 for the treatment of RA. Itis well absorbed and extensively metabolized in vivo to itsactive metabolite, 2-cyano-3-hydroxy-2-buteneamide (teriflunomide),resulting from a reductive ring opening of theisoxazole ring. Unlike MTX, teriflunomideblocks T-cell proliferation by inhibiting dihydroorotate dehydrogenase,the rate-limiting enzyme in the de novobiosynthesis of pyrimidine that is believed to be responsiblefor the immunosuppressive properties of leflunomide.For this reason, it is not surprising that leflunomide has avery comparable therapeutic efficacy to the first-lineDMARD, MTX as shown in several extended open clinicaltrials. However, even though leflunomide is well toleratedlike MTX, several cases of toxic neuropathy have beenobserved during its use, thus careful monitoring of the patient’sneurological status during treatment is mandatory.Like MTX, leflunomide is contraindicated in pregnancy orin women considering pregnancy.
- Leflunomide
-
- US $35.00-1.20 / kg
- 2024-04-18
- CAS:75706-12-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: g-kg-tons, free sample is available
- Leflunomide
-
- US $0.00 / KG
- 2024-03-16
- CAS:75706-12-6
- Min. Order: 100g
- Purity: 98%+
- Supply Ability: 100kg
- Leflunomide
-
- US $20.00 / KG
- 2023-08-16
- CAS:75706-12-6
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 20 tons
|
75706-12-6
Recommend Suppliers |
|